tadalafil (Cialis)

Following an abbreviated submission

tadalafil 2.5mg and 5mg tablets (Cialis) are accepted for use in NHS Scotland for regular once-daily administration in patients with erectile dysfunction responding to an on-demand regimen of tadalafil who anticipate frequent use (at least twice weekly).

Compared with this level of on-demand use, the low dose regular regimen is expected to be cost-neutral overall.

Tadalafil represents an alternative to other phosphodiesterase type 5 inhibitors, primarily for patients for whom the longer duration of action represents a significant advantage. This drug is subject to the same NHS prescribing restrictions as other drug treatments for erectile dysfunction in terms of National Health Service (General Medical Services) (Scotland) Regulations.